OPTIMIZATION OF HEALTHCARE FOR CHILDREN WITH RHEUMATIC DISEASES IN EPOCH OF TREATMENT WITH GENETICALLY ENGINEERED BIOLOGICAL AGENTS (BY THE EXAMPLE OF THE REPUBLIC OF BASHKORTOSTAN)
Juvenile arthritis — is the most common chronic rheumatic disorder among children, which causes rapid development of disability, decrease of the quality of life, social and psychological dysadaptation. In the majority of cases the main pathogenetic treatment is methotrexate, however when there is re...
Saved in:
| Main Authors: | G. A. Shebaev, R. M. Shakirova, V. A. Malievskii, R. Z. Akhmetshin |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
"Paediatrician" Publishers LLC
2013-12-01
|
| Series: | Вопросы современной педиатрии |
| Subjects: | |
| Online Access: | https://vsp.spr-journal.ru/jour/article/view/262 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
THE EXPERIENCE OF INFLIXIMAB USAGE IN JUVENILE ARTHRITIS IN THE REPUBLIC OF BASHKORTOSTAN
by: V. A. Malievskii, et al.
Published: (2012-11-01) -
EXPERIENCE IN APPLICATION OF TOCILIZUMAB AT SYSTEM VARIANT OF JUVENILE IDIOPATHIC ARTHRITIS IN THE REPUBLIC OF BASHKORTOSTAN
by: V. А. Malievskii, et al.
Published: (2014-05-01) -
Retrospective Cohort Study of Effectiveness and Safety of Adalimumab Use in Children with Juvenile Idiopathic Arthritis in the Republic of Bashkortostan
by: V. A. Maliyevskiy, et al.
Published: (2016-02-01) -
Efficacy of genetically engineered biological agents in the treatment of uveitis associated with rheumatic diseases in children
by: V V Neroyev, et al.
Published: (2012-08-01) -
Can remission be in juvenile idiopathic arthritis without the use of biological agents?
by: S. I. Valieva, et al.
Published: (2019-09-01)